Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 7.29 | -32.32 | 749.3 | 7.65 |
Depreciation | -112.62 | -110.77 | -96.81 | -28.87 |
Tax paid | -4.26 | -19.93 | -107.34 | -3.42 |
Working capital | -20.9 | 48.61 | -143.94 | 70.63 |
Other operating items | ||||
Operating | -130.49 | -114.42 | 401.2 | 45.98 |
Capital expenditure | 23.22 | 54.1 | 811.8 | 50.52 |
Free cash flow | -107.27 | -60.31 | 1,213 | 96.5 |
Equity raised | 16,253.43 | 16,243.88 | 11,552.64 | 7,526.94 |
Investing | -53.17 | 745.36 | 4,495.41 | 55.02 |
Financing | 1,136.89 | 1,301.68 | 869.59 | 583.69 |
Dividends paid | 0 | 0 | 0 | 0 |
Net in cash | 17,229.86 | 18,230.61 | 18,130.64 | 8,262.16 |
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice